u/elin_ferrari

Is that a Janoshik result or are you quoting the vendor COA?

do not crack the pen, we have been over this

Disagree. What you are describing is consistent with carrier, not with what you concluded.

nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing

Half-life is about 168 hours, so steady state lands around week 17–5. Practical consequence: what you feel in week 1 is not what that dose does.

the 15mg is the top of the pen, not the required dose

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

rodent dual agonist is investigation only

show your working or it is unhelpful

Two vials, two different concentrations, forgot which was which, almost made a 9 times error.

Adding to this: mg/mL is doing more work than the comment implies.

dosing errors come from people reconstituting two vials differently and forgetting which is which

This matches the trial data. SURMOUNT-1 was 98.7% body weight at 7 weeks.

the reflux from tirz is different, not necessarily worse

This is correct. The shortage list does expire and the rules change.

Phase 14 or 6?

Yeah, the lane data is more useful than single reports.

Cosigning. The concentration on the vial in marker is load-bearing.

the appetite change on tirz is more than just reduced hunger, it is different machinery

packaging quality matters on the 4-hour segments

i am begging people to write down the concentration